Pacific Biosciences is reducing both headcount and spending across its DNA sequencing business, in the face of escalating global tariffs and threats to federal biomedical research grants. | Looking to ...

In a report released yesterday, Eve Burstein from Bernstein maintained a Buy rating on Pacific Biosciences (PACB – Research Report), with a ...

Illumina ranks as the largest player in genetic sequencing. Other top genetic sequencing companies include PacBio, 10X Genomics, and Oxford Nanopore Technologies. Key findings are powered by ...

PACB), also known as PacBio, both fell 10%, while Illumina (NASDAQ:ILMN) and Bio-Rad (BIO) shares fell 5% and 4%, ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

In a report released today, Luke Sergott from Barclays maintained a Hold rating on Pacific Biosciences (PACB – Research Report), with a price ...

SAN DIEGO and CHICAGO, April 15, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) and Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine ...

PacBio to cut jobs, lower spending over NIH ... Activist investor Keith Meister to join Illumina's board Illumina said on Tuesday activist investor Keith Meister would join the gene-sequencing ...

As it faces uncertainty in the research market at home and abroad, Illumina is making changes to its board of directors, bringing on an activist investor and installing a former FDA commissioner ...

Pacific Biosciences While Offloading Illumina And Amgen Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV.

Explore Illumina stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ILMN. Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While ...